BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2068892)

  • 1. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand.
    Bang P; Eriksson U; Sara V; Wivall IL; Hall K
    Acta Endocrinol (Copenh); 1991 Jun; 124(6):620-9. PubMed ID: 2068892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoradiometric assay measurements of insulin-like growth factor-I (IGF-I): comparison with radioimmunoassays using native or des (1-3) IGF-I as radioligands.
    Homayoun P; Daher R; Van Lente F; Faiman C; Gupta MK
    J Clin Lab Anal; 1996; 10(6):446-50. PubMed ID: 8951618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.
    Powell DR; Rosenfeld RG; Baker BK; Liu F; Hintz RL
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1186-92. PubMed ID: 3760118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive proinsulin-like growth factor-II levels in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin.
    Tally M; Eriksson U; Thorén M; Brismar K; Hall K
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1576-81. PubMed ID: 7989458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium.
    Mohan S; Bautista CM; Herring SJ; Linkhart TA; Baylink DJ
    Endocrinology; 1990 May; 126(5):2534-42. PubMed ID: 1691698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU; Post KD; Powell JS; Wardlaw SL
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of various acidic treatments of bovine serum on insulin-like growth factor-I immunoreactivity and binding activity.
    Lee CY; Henricks DM
    J Endocrinol; 1990 Oct; 127(1):139-48. PubMed ID: 1715896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
    Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
    Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease.
    Gargosky SE; Hasegawa T; Tapanainen P; MacGillivray M; Hasegawa Y; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1631-7. PubMed ID: 7684745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effectiveness of various procedures for reducing or eliminating insulin-like growth factor-binding protein interference with insulin-like growth factor-I radioimmunoassays on porcine sera.
    Frey RS; Hathaway MR; Dayton WR
    J Endocrinol; 1994 Feb; 140(2):229-37. PubMed ID: 7513342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls.
    Breier BH; Gallaher BW; Gluckman PD
    J Endocrinol; 1991 Mar; 128(3):347-57. PubMed ID: 1707433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of acid-ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factors.
    Mesiano S; Young IR; Browne CA; Thorburn GD
    J Endocrinol; 1988 Dec; 119(3):453-60. PubMed ID: 2464662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus.
    Cheetham TD; Holly JM; Baxter RC; Meadows K; Jones J; Taylor AM; Dunger DB
    J Endocrinol; 1998 Apr; 157(1):81-7. PubMed ID: 9614361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II.
    Frystyk J; Dinesen B; Orskov H
    Growth Regul; 1995 Dec; 5(4):169-76. PubMed ID: 8745141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free insulin-like growth factor I (IGF-I) and IGF-II in human saliva.
    Costigan DC; Guyda HJ; Posner BI
    J Clin Endocrinol Metab; 1988 May; 66(5):1014-8. PubMed ID: 3360895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of extraction methods for insulin-like growth factor-I in rat serum.
    Crawford BA; Martin JL; Howe CJ; Handelsman DJ; Baxter RC
    J Endocrinol; 1992 Aug; 134(2):169-76. PubMed ID: 1383373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of insulin-like growth factor-binding protein-3 ternary complex in feline diabetes mellitus.
    Lewitt MS; Hazel SJ; Church DB; Watson AD; Powell SE; Tan K
    J Endocrinol; 2000 Jul; 166(1):21-7. PubMed ID: 10856879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
    Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.